Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CD19
CD19
Juno Therapeutics On a Roll in Q3 with Celgene's Cash and Lift of Clinical Hold
Motley Fool
Sun, 11/13/16 - 11:53 am
Juno Therapeutics
Celgene
CD19
Juno Therapeutics’ Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerability
Yahoo
Sun, 06/5/16 - 11:48 am
Juno Therapeutics
CD19
CAR-T
ASCO 2016
B-cell malignancies
Juno strengthens overseas position, gets $50M in expansion of Celgene deal
Bizjournals.com
Mon, 04/18/16 - 06:46 pm
Juno Therapeutics
Celgene
cancer
CD19